Načítá se...
Synergistic Neutralization of Pertussis Toxin by a Bispecific Antibody In Vitro and In Vivo
Bispecific antibodies are a rapidly growing class of therapeutic molecules, originally developed for the treatment of cancer but recently explored for the treatment of autoimmune and infectious diseases. Bordetella pertussis is a reemerging pathogen, and several of the key symptoms of infection are...
Uloženo v:
| Vydáno v: | Clin Vaccine Immunol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Microbiology
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5098018/ https://ncbi.nlm.nih.gov/pubmed/27581436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00371-16 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|